Literature DB >> 12203762

Sequential diffusion-weighted magnetic resonance imaging study of lysophosphatidyl choline-induced experimental demyelinating lesion: an animal model of multiple sclerosis.

Mahaveer N Degaonkar1, Rama Jayasundar, Naranamangalam R Jagannathan.   

Abstract

PURPOSE: To differentiate the surrounding edema from the focal demyelinating lesion during the early phase of the lesion using an apparent diffusion coefficient (ADC), and to monitor the changes in ADCs during the complete progression of a lysophosphatidyl choline (LPC)-induced experimental demyelinating lesion, an animal model of multiple sclerosis (MS).
MATERIAL AND METHODS: Eighteen rats divided into two groups-demyelinating lesion (group I, N = 12) and vehicle group (saline injected; group II, N = 6)-were studied. A 0.2-microl quantity of 1% LPC solution in isotonic saline was injected in the rat brain internal capsule (IC) area to create the demyelinating lesion. Six rats were used exclusively for histology. Diffusion-weighted (DW) images were acquired at different diffusion weightings on the 3rd, 5th, 10th, 15th, and 20th days after LPC injection. ADC was measured from three regions of interest (ROIs) within the IC: focal demyelinating lesion (area A), surrounding area of the lesion (area B), and contralateral IC area (area C).
RESULTS: Histology revealed demyelination of the IC area during the early phase of lesion progression up to day 10 and remyelination thereafter. Elevated ADCs were observed for the surrounding edematous area (area B), compared to the focal demyelinating lesion (area A) during the early phase of the demyelination process, while substantial reduction of ADCs was noticed during remyelination for both regions.
CONCLUSION: Measurement of ADC showed clear differentiation of the surrounding edema from the LPC-induced focal demyelinating lesion in rats, especially during the early phase of the lesion progression. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203762     DOI: 10.1002/jmri.10143

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  6 in total

1.  Transplantation of human adipose-derived stem cells enhances remyelination in lysolecithin-induced focal demyelination of rat spinal cord.

Authors:  Nazem Ghasemi; Shahnaz Razavi; Mohammad Mardani; Ebrahim Esfandiari; Hossein Salehi; Sayyed Hamid Zarkesh Esfahani
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.695

2.  Multi-parametric MR assessment of T(1) black holes in multiple sclerosis : evidence that myelin loss is not greater in hypointense versus isointense T(1) lesions.

Authors:  I M Vavasour; D K B Li; C Laule; A L Traboulsee; G R W Moore; A L Mackay
Journal:  J Neurol       Date:  2007-11-12       Impact factor: 4.849

3.  Evaluation of Myelin Radiotracers in the Lysolecithin Rat Model of Focal Demyelination: Beware of Pitfalls!

Authors:  Min Zhang; Gaëlle Hugon; Caroline Bouillot; Radu Bolbos; Jean-Baptiste Langlois; Thierry Billard; Frédéric Bonnefoi; Biao Li; Luc Zimmer; Fabien Chauveau
Journal:  Contrast Media Mol Imaging       Date:  2019-05-29       Impact factor: 3.161

4.  Magnetic Resonance Imaging and Spectroscopy Analysis in a Pelizaeus-Merzbacher Disease Rat Model.

Authors:  Maho Ishikawa; Reika Sawaya; Miki Hirayama; Junpei Ueda; Shigeyoshi Saito
Journal:  Diagnostics (Basel)       Date:  2022-08-02

5.  In vivo tensor-valued diffusion MRI of focal demyelination in white and deep grey matter of rodents.

Authors:  Yi He; Susana Aznar; Hartwig R Siebner; Tim B Dyrby
Journal:  Neuroimage Clin       Date:  2021-04-15       Impact factor: 4.881

Review 6.  Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models.

Authors:  Nabeela Nathoo; V Wee Yong; Jeff F Dunn
Journal:  Neuroimage Clin       Date:  2014-04-24       Impact factor: 4.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.